The U.S. Food and Drug Administration (FDA) has extended the patent on Cardiolite for pediatric applications, effective January 8.
The grant extends the marketing exclusivity of Cardiolite for an additional six months beyond its patent expiration date of January 29, 2008, for Cardiolite's new owner, private equity firm Avista Capital Partners of North Billerica, MA.
Avista acquired the medical imaging business from Bristol-Myers Squibb Medical Imaging of North Billerica, MA, on January 8.
Related Reading
Avista completes Bristol-Myers Squibb buy, January 10, 2008
Bristol-Myers Squibb finds buyer for imaging unit, December 17, 2007
Bristol breast cancer drug aims at sickest women, October 16, 2007
Bristol-Myers Squibb boosts Q2 results, July 27, 2007
Copyright © 2008 AuntMinnie.com
